THE EFFECT OF NERVE GROWTH FACTOR ON INDICATORS OF THE ANTIOXIDANT SYSTEM IN RAT BRAIN TISSUE
Abstract
The work was to study the effect of nerve growth factor (NGF) on the parameters of the antioxidant system in the rat brain. From the submandibular salivary glands of male mice, we isolated and purified fractions with nerve growth activity. We study the effect of NGF on the parameters of the antioxidant system – catalase, superoxide dismutase (SOD), and malon dialdehyde (MDA). It was found that the activity of catalase increases at a concentration of NGF of 5 μg, with a further growth of concentration of NGF a decrease in the activity of the enzyme was observed. SOD activity tends to increase at NGF concentrations of 5 and 25 μg. The decrease in the content of MDA is pronounced with the introduction of various concentrations of NGF. Thus, the activity of antioxidant enzymes tends to be restored in the presence of NGF. Neuroprotectors can exhibit therapeutic efficacy of antioxidants in neurodegenerative diseases and ischemic brain damage.
References
Overk C.R, Masliah E. Pathogenesis of synaptic degeneration in Alzheimer’s disease and Lewy body disease. Biochem. Pharmacol. 2014; 88:508-516.
Pchelina S.N: Alpha-synuclein as a biomarker of Parkinson’s disease. Annals of clinical and experimental neurology 2011; 4:46-51 (in Russian).
Alessenko A.V. Potential role of sphingolipids in neuropathogenesis of Alzheimer’s disease. Biomeditsinskaya khimiya (Biomedical Chemistry, Russia) 2013; 1:25-50 (in Russian).
Singh A., Kukreti R., Saso L., Kukreti Sh. Oxidative Stress: A key modulator in neurodegenerative diseases // Molecules. – 2019. – Vol. 24, N8. – P. 1583.
Espinet C., Gonzalo H., Fleitas C., Menal M.J., Egea J. Oxidative stress and neurodegenerative diseases: a neurotrophic approach // Curr Drug Targets. -2015. – Vol.16, N1. – P. 20-30.
Ishankhodjaev T.M., Mustafakulov M.A., Zainutdinov B.R., Ibragimova E.A., Irgasheva S.U., Saatov T.S., Mamadaliyeva N.I. Study effects of liposomal qutrcetin on biochemical parameters of the nigrostriatal system of rats with experimentally inducedneurodegenerative disease // European journal of molecular and clinical medicine. – 2020. V.7, - №11. P. 2945-2954.
CC BY-ND
A work licensed in this way allows the following:
1. The freedom to use and perform the work: The licensee must be allowed to make any use, private or public, of the work.
2. The freedom to study the work and apply the information: The licensee must be allowed to examine the work and to use the knowledge gained from the work in any way. The license may not, for example, restrict "reverse engineering."
2. The freedom to redistribute copies: Copies may be sold, swapped or given away for free, in the same form as the original.
